Lanmic Group

Lanmic Group company information, Employees & Contact Information

Explore related pages

Related company profiles:

Lanmic Group is diversified conglomerate consisting one BOI company and four local companies manufacturing and island wide distributing value added minerals mainly calcium carbonate and calcium magnesium carbonate as fillers and performance materials for many industries. Established in 1998, it is the pioneer raw material supplier for various industries. Within a span of 19 years, our group has expanded up to 5 sites, located at Seethawaka Export Processing Zone, Awissawella and Kalutara Industrial Estate with over 500 employees and 3 well equipped R and D labs. As a recipient of BOI approval for direct and indirect export, we entered the export market in 2008 by establishing LANMIC Exports (Pvt) Ltd. While responding satisfactorily to the local demand, we export a substantial quantity to Australia, Egypt, India, Pakistan, Seychelles, Middle East, and Thailand. We have strived to grow, maintaining high quality standards of the products utilizing the latest technology in the world. The company's major markets are paints, Polymers, building materials, animal feeds and detergents.

Company Details

Employees
63
Founded
-
Address
No.75, 02nd Lane, Rathmalana,western,10390,sri Lanka
Industry
Manufacturing
NAICS
Manufacturing
Beverage and Tobacco Product Manufacturing
Miscellaneous Manufacturing
Textile Furnishings Mills
Other Textile Product Mills
Other Miscellaneous Manufacturing
Carpet and Rug Mills
Curtain and Linen Mills
Textile Bag and Canvas Mills
All Other Textile Product Mills
Jewelry and Silverware Manufacturing
Doll, Toy, and Game Manufacturing
Office Supplies (except Paper) Manufacturing
Sign Manufacturing
All Other Miscellaneous Manufacturing
Rope, Cordage, Twine, Tire Cord, and Tire Fabric Mills
All Other Miscellaneous Textile Product Mills
Gasket, Packing, and Sealing Device Manufacturing
Musical Instrument Manufacturing
Fastener, Button, Needle, and Pin Manufacturing
Broom, Brush, and Mop Manufacturing
Burial Casket Manufacturing
HQ
Rathmalana, Western,
Looking for a particular Lanmic Group employee's phone or email?

Lanmic Group Questions

News

Investigation of associations between the neonatal gut microbiota and severe viral lower respiratory tract infections in the first 2 years of life: a birth cohort study with metagenomics - The Lancet

Investigation of associations between the neonatal gut microbiota and severe viral lower respiratory tract infections in the first 2 years of life: a birth cohort study with metagenomics The Lancet

Universal versus targeted chlorhexidine and mupirocin decolonisation and clinical and molecular epidemiology of Staphylococcus epidermidis bloodstream infections in patients in intensive care in Scotland, UK: a controlled time-series and longitudinal genoty - The Lancet

Universal versus targeted chlorhexidine and mupirocin decolonisation and clinical and molecular epidemiology of Staphylococcus epidermidis bloodstream infections in patients in intensive care in Scotland, UK: a controlled time-series and longitudinal genoty The Lancet

Triazole-resistant Aspergillus fumigatus in the Netherlands between 1994 and 2022: a genomic and phenotypic study - The Lancet

Triazole-resistant Aspergillus fumigatus in the Netherlands between 1994 and 2022: a genomic and phenotypic study The Lancet

Laboratory-acquired infections and pathogen escapes worldwide between 2000 and 2021: a scoping review - The Lancet

Laboratory-acquired infections and pathogen escapes worldwide between 2000 and 2021: a scoping review The Lancet

Antimicrobial resistance: a concise update - The Lancet

Antimicrobial resistance: a concise update The Lancet

Impact of climate change and natural disasters on fungal infections - The Lancet

Impact of climate change and natural disasters on fungal infections The Lancet

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study - The Lancet

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study The Lancet

Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation in the USA in 2021: report of an investigation - The Lancet

Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation in the USA in 2021: report of an investigation The Lancet

Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study - The Lancet

Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study The Lancet

WHO publishes updated list of bacterial priority pathogens - The Lancet

WHO publishes updated list of bacterial priority pathogens The Lancet

The 2023 WHO World malaria report - The Lancet

The 2023 WHO World malaria report The Lancet

WHO's Global Tuberculosis Report 2022 - The Lancet

WHO's Global Tuberculosis Report 2022 The Lancet

Mpox respiratory transmission: the state of the evidence - The Lancet

Mpox respiratory transmission: the state of the evidence The Lancet

Global prevalence of cervical human papillomavirus in women aged 50 years and older with normal cytology: a systematic review and meta-analysis - The Lancet

Global prevalence of cervical human papillomavirus in women aged 50 years and older with normal cytology: a systematic review and meta-analysis The Lancet

Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials - The Lancet

Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials The Lancet

The Lancet Microbe Home Page - The Lancet

The Lancet Microbe Home Page The Lancet

COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room - The Lancet

COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room The Lancet

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis - The Lancet

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis The Lancet

Invasive mould disease in fatal COVID-19: a systematic review of autopsies - The Lancet

Invasive mould disease in fatal COVID-19: a systematic review of autopsies The Lancet

Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study - The Lancet

Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study The Lancet

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study - The Lancet

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study The Lancet

Top Lanmic Group Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant